Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Grows By 4,963.5%

Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) was the target of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 374,700 shares, a growth of 4,963.5% from the August 15th total of 7,400 shares. Based on an average trading volume of 108,200 shares, the days-to-cover ratio is presently 3.5 days.

Hedge Funds Weigh In On Global X Genomics & Biotechnology ETF

Large investors have recently made changes to their positions in the company. Money Concepts Capital Corp bought a new stake in Global X Genomics & Biotechnology ETF during the 4th quarter worth approximately $25,000. OLD Mission Capital LLC bought a new stake in Global X Genomics & Biotechnology ETF during the 4th quarter worth approximately $37,000. IFP Advisors Inc increased its stake in Global X Genomics & Biotechnology ETF by 121.0% during the 2nd quarter. IFP Advisors Inc now owns 3,521 shares of the company’s stock worth $53,000 after purchasing an additional 1,928 shares in the last quarter. Advisor Group Holdings Inc. grew its stake in shares of Global X Genomics & Biotechnology ETF by 26.9% during the 4th quarter. Advisor Group Holdings Inc. now owns 3,916 shares of the company’s stock worth $49,000 after acquiring an additional 831 shares in the last quarter. Finally, Rockefeller Capital Management L.P. grew its stake in shares of Global X Genomics & Biotechnology ETF by 19.4% during the 4th quarter. Rockefeller Capital Management L.P. now owns 9,200 shares of the company’s stock worth $116,000 after acquiring an additional 1,493 shares in the last quarter. Institutional investors and hedge funds own 56.95% of the company’s stock.

Global X Genomics & Biotechnology ETF Stock Down 0.5 %

Shares of GNOM opened at $11.03 on Friday. Global X Genomics & Biotechnology ETF has a 12-month low of $10.70 and a 12-month high of $14.36. The firm has a market capitalization of $181.88 million, a PE ratio of -4.71 and a beta of 1.03. The stock’s fifty day simple moving average is $11.57 and its 200-day simple moving average is $12.19.

About Global X Genomics & Biotechnology ETF

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.